While the higher assay sensitivity makes orthogonal catalytic DNA nanomachines promising for imaging analysis in living biosamples, the absence of specific recognition components and the persistent "always-on" state for biomolecular identification hinder their further application. Hereby, we establish an endogenous mRNA (mRNA)-stimulative self-enhanced orthogonal catalytic DNA nanomachine mediated by near-infrared (NIR) light. Initially, a catalytic hairpin assembly and entropy-driven catalysis cascaded self-enhanced circuit is equipped with a component specific to TK1 mRNA recognition, enabling highly selective sensing initiation. Furthermore, the interior of a DNA segment is inserted with a photocleavable bond to lock the biomolecular identification, followed by NIR light mediation of up-converting luminescence to avoid premature activation of the sensing system during biodelivery. By selecting a cancer-correlated noncoding microRNA biomarker (miRNA-21) for conceptual illustration, this newly devised DNA nanomachine exhibits remarkably sensitive sensing capability with good specificity in solution detection. Delving deeper, our sensing methodology reliably achieves high-performance imaging of this low-abundance target in living biosamples, covering both the cellular and in vivo levels. This drives forward the advancement of DNA nanomachine-built fluorescent biosensors in disease diagnosis.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: